Behind the science

Is prevention the ‘medicine’ we need to end the HIV epidemic?

We spoke to scientists and advocates at the forefront of the race to end the HIV epidemic by 2030 to find out what role they think prevention can play in achieving this goal.

Read our article on HIV
Two people hugging
Close Video

Our purpose

We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.

Our R&D focus is on four therapeutic areas: infectious diseases, HIV, immunology/respiratory and oncology

Infectious diseases
1 in 6
deaths globally caused by infectious disease
Go to infectious diseases
HIV
39m
people living with HIV globally
Go to HIV
Respiratory/Immunology
50yrs
of leading research to help people with respiratory and inflammatory conditions
Go to respiratory/immunology
Oncology
~10m
people died from cancer in 2020, making it a leading cause of death worldwide
Go to oncology

Behind the science

Discover how we're getting ahead

‘This could be a golden moment’: Is prevention the ‘medicine’ we need to end the HIV epidemic?

Remission could be possible for people with asthma, giving them a new outlook on life

‘We’ve seen an explosion in computing power’: Using AI, machine learning and data to unlock the mysteries of disease

‘Patients can breathe easier today’: Scientific advances in asthma and COPD care could prevent irreversible lung damage

Advanced technology is increasing the chances of improving outcomes for cancer patients

Robots, AI, and machine learning: how smart manufacturing is getting medicines and vaccines from factories to patients faster
Read our magazine

Life at GSK

Find out what it's like to work with us

make a difference

Make a difference with us

With our innovation, scale and global partnerships, working with us presents a unique opportunity to impact the lives of billions.

Hear what Zack has to say

do your best work

Do your best work with us

To get ahead of disease together, continuous growth and development are vital. At GSK you'll expand your skills and build valuable connections, enabling you to do your best work.

Hear what Sarah and Martha have to say

Be yourself

Be yourself with us

We've built an inclusive and supportive culture, so that you can pursue your professional goals without compromising on what matters most.

Hear what Tammeka has to say

Careers at GSK
pinch icon pinch icon

Positively impacting society and the planet

Baby laughing

Access

We are making our products affordable and available to more people around the world through responsible pricing, strategic access programmes and partnerships.

Scientist inspecting a vial

Global health and health security

We are committed to change the trajectory of high burden diseases in lower-income countries with a focus on prevention and treatment of infectious diseases.

Solar panels with a rainbow in Irvine

Environment

We're committed to work towards a net zero, nature positive, healthier planet, with ambitious goals set for 2030 and 2045.

Scientist in laboratory

Diversity, equity and inclusion

Our work supports the health of all kinds of people. To meet our diverse patients' needs better, we need diversity in our clinical trials and to support our own people to thrive as part of an inclusive team.

Group of scientists in the lab

Ethical standards

Our culture guides our people to do the right thing and act on any concerns they have.

Scientist in conversation

Product governance

Ensuring the quality, safety and reliable supply of our products is critical to our purpose of uniting science, talent and technology to get ahead of disease together.

INVESTORS

We announced our third quarter 2024 results on Wednesday 30 October

View latest results

Continue to Company